Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine.
Division of Craniofacial Function Engineering, Tohoku University Graduate School of Dentistry.
Tohoku J Exp Med. 2023 Jul 14;260(3):245-252. doi: 10.1620/tjem.2023.J040. Epub 2023 May 18.
In clinical settings, bone grafting is frequently used to treat bone defects. Therefore, the development of bone graft substitutes with superior bone formation ability is expected, instead of autogenous bone grafting. Octacalcium phosphate (OCP) has been developed as a bone graft substitute, and preclinical studies using OCP have reported superior bone formation ability compared with β-tricalcium phosphate. Furthermore, OCP has been used in composite forms with natural polymers such as collagen and gelatin to improve the usability of OCP, and OCP/collagen composite forms have been clinically applied in the dental field because of their excellent usability and osteogenic potential. This review describes the development and preclinical results of OCP and OCP/gelatin (OCP/Gel) composites and prospects for future applications in orthopedics. The development of bone graft substitutes that achieve a high degree of biodegradability and strength will be needed for the clinical application of OCP composites in orthopedics in the future.
在临床环境中,经常使用骨移植来治疗骨缺损。因此,人们期望开发出具有更好成骨能力的骨移植替代物,而不是自体骨移植。八钙磷酸盐(OCP)已被开发为骨移植替代物,使用 OCP 的临床前研究报告称其成骨能力优于β-磷酸三钙。此外,OCP 已与天然聚合物如胶原和明胶复合使用,以提高 OCP 的可用性,并且由于其出色的可用性和成骨潜力,OCP/胶原复合材料已在牙科领域临床应用。本文综述了 OCP 和 OCP/明胶(OCP/Gel)复合材料的开发和临床前研究结果,并展望了其在骨科领域的未来应用前景。未来,OCP 复合材料在骨科中的临床应用需要开发出具有高度可生物降解性和强度的骨移植替代物。